Myomar Nears Commercialization, Almost $1M Raised

Halifax medical testing startup Myomar Molecular is conducting the first beta tests of its product as it nears the close of a $1 million funding round, with $900,000 committed.
Founder Rafaela Andrade said in an interview the testing began in September and will be finished by December. The participants have been recruited from the general population in Nova Scotia and signed up via Myomar’s